These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12871135)

  • 1. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 4. Aldose reductase expression as a risk factor for cataract.
    Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
    Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 6. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
    Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
    Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 10. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S
    Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S; Buyukbingol E
    Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
    Kinoshita JH
    Am J Ophthalmol; 1986 Dec; 102(6):685-92. PubMed ID: 3098107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5'-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus.
    Ichikawa F; Yamada K; Ishiyama-Shigemoto S; Yuan X; Nonaka K
    Diabet Med; 1999 Sep; 16(9):744-8. PubMed ID: 10510950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.
    Chang KC; Petrash JM
    Adv Exp Med Biol; 2018; 1032():173-202. PubMed ID: 30362099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.
    Park J; Kim H; Park SY; Lim SW; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kwon HM; Choi WS
    Exp Eye Res; 2014 May; 122():13-9. PubMed ID: 24631337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications.
    Demaine AG
    Curr Med Chem; 2003 Aug; 10(15):1389-98. PubMed ID: 12871136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
    Lee AY; Chung SK; Chung SS
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2780-4. PubMed ID: 7708723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitors and cataract.
    Crabbe MJ
    Int Ophthalmol; 1991 Jan; 15(1):25-36. PubMed ID: 1901300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible genetic causes for late complications of diabetes mellitus].
    Klemm T; Paschke R
    Med Klin (Munich); 2000 Jan; 95(1):31-9. PubMed ID: 10668342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.